Publications
  1. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics

    Italian Soc Nephrology, Provenzano, M., Chiodini, P., Minutolo, R., Zoccali, C., Bellizzi, V., Conte, G., Locatelli, F., Tripepi, G., Del Vecchio, L., Mallamaci, F., Di Micco, L., Russo, D., Heerspink, H. J. L. & De Nicola, L., Jan-2020, In : Nephrology Dialysis Transplantation. 35, 1, p. 138-147 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes

    van Bommel, E. J. M., Smits, M. M., Ruiter, D., Muskiet, M. H. A., Kramer, M. H. H., Nieuwdorp, M., Touw, D. J., Heerspink, H. J. L., Joles, J. A. & van Raalte, D. H., 6-Jun-2020, In : Journal of Hypertension. 38, 1, 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (298) »

Press / Media
  1. Pills for protecting kidneys to reduce need of dialysis

    Hiddo Lambers Heerspink

    17/09/2019

    1 item of Media coverage

    Press/Media: Public Engagement ActivitiesPopular

View all (1) »

Activities
  1. Asian-Australian Diabetes Meeting

    Hiddo Lambers Heerspink (Invited speaker)
    24-Aug-2019

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  2. European Association for the Study of Diabetes (EASD) Barcelona 2019

    Hiddo Lambers Heerspink (Invited speaker)
    17-Sep-2019

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  3. ASN Kidney week

    Hiddo Lambers Heerspink (Speaker)
    7-Nov-20199-Nov-2019

    Activity: Talk or presentationAcademic

View all (16) »

ID: 208085